candidate_genes,disease,celltype,y,user_question,full_query
"['RRM1', 'PTGES3', 'ERICH4', 'PCP2', 'TRPM2']",Hepatoblastoma,endothelial,RRM1,"Which gene among RRM1, PTGES3, ERICH4, PCP2, and TRPM2 exhibits the highest endothelial cell specificity, making it the most promising candidate for targeted hepatoblastoma therapy?","Which gene among RRM1, PTGES3, ERICH4, PCP2, and TRPM2 exhibits the highest endothelial cell specificity, making it the most promising candidate for targeted hepatoblastoma therapy? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which endothelial-activated genes in PINNACLE overlap with these targets, forming the set of cell-type–specific targets for Hepatoblastoma. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CASKIN2', 'SHANK2', 'POLE3', 'NUDT19', 'CREM']",Hepatoblastoma,endothelial,POLE3,"Which gene among CASKIN2, SHANK2, POLE3, NUDT19, and CREM exhibits the most endothelial cell-specific expression, thereby indicating its potential as a targeted candidate for hepatoblastoma?","Which gene among CASKIN2, SHANK2, POLE3, NUDT19, and CREM exhibits the most endothelial cell-specific expression, thereby indicating its potential as a targeted candidate for hepatoblastoma? Using validated therapeutic targets for Hepatoblastoma, extract their cell-type–specific embeddings from the PINNACLE dataset. Identify which of these targets overlap with endothelial-activated genes in PINNACLE to define the cell-type–specific target set. Compute the average embedding for this set as a reference and then calculate the cosine similarity between the reference and each individual target. If a gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['XPC', 'POLD2', 'TMEM135', 'NXF1', 'YWHAB']",Hepatoblastoma,endothelial,POLD2,"Which gene among XPC, POLD2, TMEM135, NXF1, and YWHAB exhibits the highest endothelial cell-type specificity for targeting hepatoblastoma?","Which gene among XPC, POLD2, TMEM135, NXF1, and YWHAB exhibits the highest endothelial cell-type specificity for targeting hepatoblastoma? Identify the validated therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the endothelial-activated genes in PINNACLE overlap with these targets to define the relevant cell-type–specific targets for hepatoblastoma. Compute the average embedding for this overlapping set and then calculate the cosine similarity between the average and each individual target gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FLT4', 'NAPSA', 'IL5RA', 'PPP2R1B', 'TAF3']",Hepatoblastoma,endothelial,FLT4,"Which gene among FLT4, NAPSA, IL5RA, PPP2R1B, and TAF3 exhibits the highest endothelial cell-type specificity for strategies aimed at targeting hepatoblastoma?","Which gene among FLT4, NAPSA, IL5RA, PPP2R1B, and TAF3 exhibits the highest endothelial cell-type specificity for strategies aimed at targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with endothelial-activated genes in PINNACLE. Calculate the average embedding of this overlapping set, then compute the cosine similarity between this reference embedding and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ZNF219', 'ZNF710', 'PRIM2', 'TM9SF1', 'CRNKL1']",Hepatoblastoma,endothelial,PRIM2,"Among the genes ZNF219, ZNF710, PRIM2, TM9SF1, and CRNKL1, which one exhibits the highest specificity in endothelial cells for targeted hepatoblastoma therapy?","Among the genes ZNF219, ZNF710, PRIM2, TM9SF1, and CRNKL1, which one exhibits the highest specificity in endothelial cells for targeted hepatoblastoma therapy? Identify validated therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the endothelial-activated genes in PINNACLE. Calculate the average embedding of these overlapping genes to establish a reference, and then compute the cosine similarity between the reference and each target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['EXOC3-AS1', 'LST1', 'SPAST', 'TOP2A', 'SHANK1']",Hepatoblastoma,endothelial,TOP2A,"Which gene among EXOC3-AS1, LST1, SPAST, TOP2A, and SHANK1 exhibits the highest specificity for endothelial cells in the context of hepatoblastoma targeting?","Which gene among EXOC3-AS1, LST1, SPAST, TOP2A, and SHANK1 exhibits the highest specificity for endothelial cells in the context of hepatoblastoma targeting? Using the verified therapeutic targets for hepatoblastoma, extract their cell-type specific embeddings from PINNACLE. Identify the endothelial-activated genes in PINNACLE that overlap with these therapeutic targets to define the cell-type specific targets for hepatoblastoma. Then, compute the average embedding for these genes and calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLD3', 'AGFG1', 'LRP2BP', 'CCKBR', 'ABCC9']",Hepatoblastoma,endothelial,POLD3,"Among the following genes—POLD3, AGFG1, LRP2BP, CCKBR, and ABCC9—which exhibits the highest specificity for endothelial cells and represents the best candidate target for hepatoblastoma therapy?","Among the following genes—POLD3, AGFG1, LRP2BP, CCKBR, and ABCC9—which exhibits the highest specificity for endothelial cells and represents the best candidate target for hepatoblastoma therapy? Identify the validated therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial-activated genes in PINNACLE overlap with these targets, designating this intersection as the cell-type–specific targets for Hepatoblastoma. Compute the average embedding for these targets, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KIT', 'AKT1', 'CD33', 'GRAMD4', 'RAN']",Hepatoblastoma,endothelial,KIT,"Among the genes KIT, AKT1, CD33, GRAMD4, and RAN, which one demonstrates the highest cell-type specificity for endothelial cells in the context of targeting hepatoblastoma?","Among the genes KIT, AKT1, CD33, GRAMD4, and RAN, which one demonstrates the highest cell-type specificity for endothelial cells in the context of targeting hepatoblastoma? Using the PINNACLE framework, identify verified therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings. Next, determine the overlap between these targets and the endothelial-activated genes provided by PINNACLE, resulting in a set of cell-type–specific targets. Calculate the average embedding for these overlapping genes and compute the cosine similarity of each individual gene's embedding to this reference. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DBN1', 'TUBB4B', 'ZNF83', 'MYO1B', 'CENPK']",Hepatoblastoma,endothelial,TUBB4B,"Which gene among DBN1, TUBB4B, ZNF83, MYO1B, and CENPK exhibits the highest specificity to endothelial cells for potential therapeutic targeting in hepatoblastoma?","Which gene among DBN1, TUBB4B, ZNF83, MYO1B, and CENPK exhibits the highest specificity to endothelial cells for potential therapeutic targeting in hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the intersection between these targets and the endothelial-activated genes in PINNACLE to define the cell-type–specific target set for hepatoblastoma. Compute the average embedding for this subset and then calculate the cosine similarity between this average and each individual target embedding. Finally, if one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TXN', 'MLF2', 'PRIM1', 'CLSTN1', 'KDM2A']",Hepatoblastoma,endothelial,PRIM1,"Among TXN, MLF2, PRIM1, CLSTN1, and KDM2A, which gene exhibits the highest endothelial cell-specific expression for targeting Hepatoblastoma?","Among TXN, MLF2, PRIM1, CLSTN1, and KDM2A, which gene exhibits the highest endothelial cell-specific expression for targeting Hepatoblastoma? Identify validated therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the endothelial-activated genes in PINNACLE to define cell-type–specific targets. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NTRK1', 'RALGAPA2', 'TOP1', 'ZNF627', 'TELO2']",Hepatoblastoma,endothelial,TOP1,"Which gene among NTRK1, RALGAPA2, TOP1, ZNF627, and TELO2 exhibits the highest specificity in endothelial cells for targeting hepatoblastoma?","Which gene among NTRK1, RALGAPA2, TOP1, ZNF627, and TELO2 exhibits the highest specificity in endothelial cells for targeting hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Determine which of these targets overlap with the set of endothelial-activated genes in PINNACLE to define the cell-type–specific therapeutic targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PALB2', 'PPP1R21', 'TOP2B', 'PACRG', 'ASCC2']",Hepatoblastoma,endothelial,TOP2B,"Which gene among PALB2, PPP1R21, TOP2B, PACRG, and ASCC2 exhibits the highest specificity in endothelial cells, making it the optimal candidate for targeting hepatoblastoma?","Which gene among PALB2, PPP1R21, TOP2B, PACRG, and ASCC2 exhibits the highest specificity in endothelial cells, making it the optimal candidate for targeting hepatoblastoma? What are the experimentally verified therapeutic targets for hepatoblastoma, and how do their cell-type–specific embeddings from PINNACLE compare with those of endothelial-activated genes? Identify the overlapping genes between these two datasets to define the cell-type–specific targets for hepatoblastoma, compute their average embedding, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['DTX3L', 'TYMS', 'RASAL3', 'NDUFA9', 'MAD2L1']",Hepatoblastoma,endothelial,TYMS,"Which gene among DTX3L, TYMS, RASAL3, NDUFA9, and MAD2L1 exhibits the highest specificity for endothelial cells when considering targeted approaches for hepatoblastoma?","Which gene among DTX3L, TYMS, RASAL3, NDUFA9, and MAD2L1 exhibits the highest specificity for endothelial cells when considering targeted approaches for hepatoblastoma? Identify validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Among the endothelial-activated genes in PINNACLE, identify those that overlap with these targets to define the cell-type–specific therapeutic targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TUBB', 'PAGR1', 'KLHDC4', 'AHR', 'DIO3']",Hepatoblastoma,endothelial,TUBB,"Which gene among TUBB, PAGR1, KLHDC4, AHR, and DIO3 exhibits the highest endothelial cell specificity for targeted intervention in hepatoblastoma?","Which gene among TUBB, PAGR1, KLHDC4, AHR, and DIO3 exhibits the highest endothelial cell specificity for targeted intervention in hepatoblastoma? Identify verified therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the endothelial-activated genes in PINNACLE, thereby defining the cell-type–specific targets for Hepatoblastoma. Compute the average embedding for this overlapping set as a reference, then assess the cosine similarity between the reference and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological significance."
"['POLE2', 'PPFIA2', 'RBMY1F', 'MN1', 'HIVEP2']",Hepatoblastoma,endothelial,POLE2,"Which gene among POLE2, PPFIA2, RBMY1F, MN1, and HIVEP2 demonstrates the most endothelial-specific expression, making it the optimal candidate for targeted hepatoblastoma intervention?","Which gene among POLE2, PPFIA2, RBMY1F, MN1, and HIVEP2 demonstrates the most endothelial-specific expression, making it the optimal candidate for targeted hepatoblastoma intervention? Determine the validated therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the endothelial-activated genes in PINNACLE to establish a set of cell-type–specific targets for Hepatoblastoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['GRXCR1', 'MTHFSD', 'SLC10A1', 'FLT1', 'STX5']",Hepatoblastoma,endothelial,FLT1,"Among the genes GRXCR1, MTHFSD, SLC10A1, FLT1, and STX5, which one exhibits the highest specificity for endothelial cells, making it the best candidate for targeting Hepatoblastoma?","Among the genes GRXCR1, MTHFSD, SLC10A1, FLT1, and STX5, which one exhibits the highest specificity for endothelial cells, making it the best candidate for targeting Hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the endothelial-activated genes in PINNACLE, thereby defining a set of cell-type–specific targets. Compute the average embedding of this set and calculate the cosine similarity between this reference vector and each individual target's embedding. If one gene exhibits a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KDR', 'EMX1', 'GDF10', 'MRGPRX2', 'DEPTOR']",Hepatoblastoma,endothelial,KDR,"Among KDR, EMX1, GDF10, MRGPRX2, and DEPTOR, which gene exhibits the highest endothelial cell specificity for potential targeted intervention in hepatoblastoma?","Among KDR, EMX1, GDF10, MRGPRX2, and DEPTOR, which gene exhibits the highest endothelial cell specificity for potential targeted intervention in hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the endothelial-activated genes in PINNACLE to define the cell-type–specific targets for Hepatoblastoma. Compute the average embedding for these overlapping targets as a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PLTP', 'TRAPPC5', 'FLT4', 'FCER1G', 'DUT']",Hepatoblastoma,endothelial,FLT4,"Among PLTP, TRAPPC5, FLT4, FCER1G, and DUT, which gene exhibits the highest endothelial cell-type specificity as an optimal target for Hepatoblastoma treatment?","Among PLTP, TRAPPC5, FLT4, FCER1G, and DUT, which gene exhibits the highest endothelial cell-type specificity as an optimal target for Hepatoblastoma treatment? Identify the validated therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the endothelial-activated genes in PINNACLE. Compute the average embedding of the overlapping targets and calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a brief evidence-based rationale for its biological relevance."
"['CLDN11', 'PRPF40B', 'KDR', 'POLR2E', 'CHRNB2']",Hepatoblastoma,endothelial,KDR,"Which gene among CLDN11, PRPF40B, KDR, POLR2E, and CHRNB2 demonstrates the highest endothelial cell-specific expression for targeted hepatoblastoma intervention?","Which gene among CLDN11, PRPF40B, KDR, POLR2E, and CHRNB2 demonstrates the highest endothelial cell-specific expression for targeted hepatoblastoma intervention? Identify the verified therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial-activated genes in PINNACLE overlap with these targets, creating a set of cell-type–specific Hepatoblastoma targets. Compute the average embedding for this set and then calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PNPLA6', 'CBX6', 'MGAT4A', 'CLCN4', 'KIT']",Hepatoblastoma,endothelial,KIT,"Which gene among PNPLA6, CBX6, MGAT4A, CLCN4, and KIT exhibits the highest endothelial cell-type specificity for targeting Hepatoblastoma?","Which gene among PNPLA6, CBX6, MGAT4A, CLCN4, and KIT exhibits the highest endothelial cell-type specificity for targeting Hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which endothelial-activated genes within PINNACLE overlap with these targets to define a cell-type–specific candidate set. Compute the average embedding of this set to serve as a reference, then calculate the cosine similarity between this reference and each target gene. If one gene exhibits a markedly higher similarity than the others, select it as the leading candidate and provide a concise, evidence-based explanation of its biological significance."
"['U2AF1L5', 'UBOX5', 'LAMTOR4', 'HOXC9', 'TOP2B']",Hepatoblastoma,kupffer cell,TOP2B,"Among U2AF1L5, UBOX5, LAMTOR4, HOXC9, and TOP2B, which gene displays the highest specificity of expression in Kupffer cells, making it the most promising target for hepatoblastoma intervention?","Among U2AF1L5, UBOX5, LAMTOR4, HOXC9, and TOP2B, which gene displays the highest specificity of expression in Kupffer cells, making it the most promising target for hepatoblastoma intervention? Identify the verified therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in Kupffer cells to define cell-type–specific targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ABCB7', 'NPBWR2', 'PRIM1', 'AVP', 'EPN1']",Hepatoblastoma,kupffer cell,PRIM1,"Which gene among ABCB7, NPBWR2, PRIM1, AVP, and EPN1 exhibits the greatest cell-type specificity in Kupffer cells for targeting hepatoblastoma?","Which gene among ABCB7, NPBWR2, PRIM1, AVP, and EPN1 exhibits the greatest cell-type specificity in Kupffer cells for targeting hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in kupffer cells in PINNACLE to define a set of hepatoblastoma-specific targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference embedding and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UBXN2B', 'ENPP3', 'TOP1', 'TGFBR1', 'COL10A1']",Hepatoblastoma,kupffer cell,TOP1,"Which gene among UBXN2B, ENPP3, TOP1, TGFBR1, and COL10A1 exhibits the highest specificity to Kupffer cells, thereby representing the most promising candidate for hepatoblastoma-targeted strategies?","Which gene among UBXN2B, ENPP3, TOP1, TGFBR1, and COL10A1 exhibits the highest specificity to Kupffer cells, thereby representing the most promising candidate for hepatoblastoma-targeted strategies? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which Kupffer cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding for the overlapping set, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FLT1', 'NPHS1', 'PIPOX', 'MAPK8IP1', 'TNFAIP3']",Hepatoblastoma,kupffer cell,FLT1,"Which gene among FLT1, NPHS1, PIPOX, MAPK8IP1, and TNFAIP3 exhibits the highest cell-type specificity in Kupffer cells, making it the most promising target for hepatoblastoma therapy?","Which gene among FLT1, NPHS1, PIPOX, MAPK8IP1, and TNFAIP3 exhibits the highest cell-type specificity in Kupffer cells, making it the most promising target for hepatoblastoma therapy? Using verified therapeutic targets for Hepatoblastoma, retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets are also activated in Kupffer cells according to PINNACLE. Calculate the average embedding of this overlapping gene set, then evaluate the cosine similarity between this average and the embedding of each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance in Hepatoblastoma therapy."
"['TPGS1', 'SPAG11B', 'TPP1', 'CAV1', 'TUBB']",Hepatoblastoma,kupffer cell,TUBB,"Among the genes TPGS1, SPAG11B, TPP1, CAV1, and TUBB, which one exhibits the highest specificity in Kupffer cells and represents the best candidate for targeting hepatoblastoma?","Among the genes TPGS1, SPAG11B, TPP1, CAV1, and TUBB, which one exhibits the highest specificity in Kupffer cells and represents the best candidate for targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Determine which genes activated in Kupffer cells overlap with these targets, thereby defining the cell-type–specific targets for hepatoblastoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NR5A1', 'TUBB4B', 'MID2', 'LUZP6', 'C8A']",Hepatoblastoma,kupffer cell,TUBB4B,"Which gene among NR5A1, TUBB4B, MID2, LUZP6, and C8A exhibits the highest cell-type specificity in Kupffer cells, making it the most effective candidate for targeting hepatoblastoma?","Which gene among NR5A1, TUBB4B, MID2, LUZP6, and C8A exhibits the highest cell-type specificity in Kupffer cells, making it the most effective candidate for targeting hepatoblastoma? Determine the validated therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, identify which of these targets overlap with the genes activated in Kupffer cells according to PINNACLE, thereby defining the cell-type–specific targets for Hepatoblastoma. Compute the average embedding for these overlapping genes and assess the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['IQGAP3', 'TYMS', 'LARP6', 'CAPN10', 'FAP']",Hepatoblastoma,kupffer cell,TYMS,"Which gene among IQGAP3, TYMS, LARP6, CAPN10, and FAP exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma?","Which gene among IQGAP3, TYMS, LARP6, CAPN10, and FAP exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma? Identify validated therapeutic targets for Hepatoblastoma and extract their cell-type specific embeddings from PINNACLE. Next, determine which genes in the Kupffer cell–activated set overlap with these targets. Calculate the average embedding of this overlapping set as a reference vector, then compute the cosine similarity between this reference and each individual overlapping gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in Hepatoblastoma."
"['LALBA', 'GOLGA6A', 'GYG2', 'POLD3', 'CINP']",Hepatoblastoma,kupffer cell,POLD3,"Which gene among LALBA, GOLGA6A, GYG2, POLD3, and CINP exhibits the highest cell-type specificity in Kupffer cells for targeted hepatoblastoma therapy?","Which gene among LALBA, GOLGA6A, GYG2, POLD3, and CINP exhibits the highest cell-type specificity in Kupffer cells for targeted hepatoblastoma therapy? Given the set of validated therapeutic targets for Hepatoblastoma, retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify which of these targets overlap with kupffer cell–activated genes in PINNACLE. For the overlapping genes, compute an average embedding to serve as a reference, then determine the cosine similarity between this reference and each target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological significance."
"['AAMP', 'GTF2H2C', 'POLA1', 'GCM2', 'CCDC88B']",Hepatoblastoma,kupffer cell,POLA1,"Which gene among AAMP, GTF2H2C, POLA1, GCM2, and CCDC88B shows the highest specificity for Kupffer cells, thereby representing the most promising target for hepatoblastoma treatment?","Which gene among AAMP, GTF2H2C, POLA1, GCM2, and CCDC88B shows the highest specificity for Kupffer cells, thereby representing the most promising target for hepatoblastoma treatment? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the Kupffer cell–activated genes, compute the average embedding of this overlapping set, and calculate the cosine similarity between each individual target’s embedding and this average. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HOXD1', 'LZTS2', 'MS4A14', 'POLA2', 'TRIM16']",Hepatoblastoma,kupffer cell,POLA2,"Among the genes HOXD1, LZTS2, MS4A14, POLA2, and TRIM16, which exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma?","Among the genes HOXD1, LZTS2, MS4A14, POLA2, and TRIM16, which exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma? Identify validated therapeutic targets for Hepatoblastoma and extract their corresponding cell-type-specific embeddings from the PINNACLE database. Next, determine which genes activated in Kupffer cells overlap with these targets, thereby defining a cell-type-specific target set for Hepatoblastoma. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene distinctly exhibits higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ALPP', 'GK3P', 'NKX2-5', 'C16orf74', 'TOP2A']",Hepatoblastoma,kupffer cell,TOP2A,"Which gene among ALPP, GK3P, NKX2-5, C16orf74, and TOP2A exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma?","Which gene among ALPP, GK3P, NKX2-5, C16orf74, and TOP2A exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which kupffer cell-activated genes from PINNACLE overlap with these targets, forming a set of cell-type–specific therapeutic candidates. Calculate the average embedding for these candidates and assess the cosine similarity between this composite embedding and each individual target. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SMG7', 'RRM1', 'LRRC1', 'DUSP10', 'RP9']",Hepatoblastoma,kupffer cell,RRM1,"Which gene among SMG7, RRM1, LRRC1, DUSP10, and RP9 exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma?","Which gene among SMG7, RRM1, LRRC1, DUSP10, and RP9 exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma? What are the verified therapeutic targets for hepatoblastoma that also overlap with kupffer cell–activated genes in PINNACLE? Retrieve the cell-type–specific embeddings for these targets, compute their average embedding as a reference, and then calculate the cosine similarity between this reference and each individual target. Identify the single gene with a markedly higher similarity as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PRIM2', 'ASB8', 'INHBC', 'NEU2', 'JAGN1']",Hepatoblastoma,kupffer cell,PRIM2,"Among PRIM2, ASB8, INHBC, NEU2, and JAGN1, which gene exhibits the highest cell-type specificity in Kupffer cells, thereby representing the most promising target for hepatoblastoma therapy?","Among PRIM2, ASB8, INHBC, NEU2, and JAGN1, which gene exhibits the highest cell-type specificity in Kupffer cells, thereby representing the most promising target for hepatoblastoma therapy? Identify the verified therapeutic targets for Hepatoblastoma and extract their cell-type-specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the Kupffer cell-activated genes available in PINNACLE to define the cell-type–specific targets for Hepatoblastoma. Compute the average embedding of these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLE2', 'SLCO1B3', 'ZNF547', 'ATP1A4', 'MAGEC1']",Hepatoblastoma,kupffer cell,POLE2,"Among POLE2, SLCO1B3, ZNF547, ATP1A4, and MAGEC1, which gene exhibits the highest cellular specificity for Kupffer cells as a candidate target in hepatoblastoma?","Among POLE2, SLCO1B3, ZNF547, ATP1A4, and MAGEC1, which gene exhibits the highest cellular specificity for Kupffer cells as a candidate target in hepatoblastoma? Identify the verified therapeutic targets for Hepatoblastoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with kupffer cell-activated genes in PINNACLE, making them potential cell-type–specific targets. Calculate the average embedding of this overlapping set and assess the cosine similarity between each individual target's embedding and this average reference. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its relevance in Hepatoblastoma."
"['TOP2B', 'UTS2R', 'EGR2', 'DCAF1', 'SETD3']",Hepatoblastoma,kupffer cell,TOP2B,"Which gene among TOP2B, UTS2R, EGR2, DCAF1, and SETD3 exhibits the highest cell-type-specific expression in Kupffer cells, making it the most promising target for Hepatoblastoma therapy?","Which gene among TOP2B, UTS2R, EGR2, DCAF1, and SETD3 exhibits the highest cell-type-specific expression in Kupffer cells, making it the most promising target for Hepatoblastoma therapy? Identify the validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with Kupffer cell–activated genes in PINNACLE, and compute the average embedding for this overlapping set. Then, calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological importance."
"['MICALL1', 'MRPL23', 'ARHGEF40', 'TOP1', 'FERD3L']",Hepatoblastoma,kupffer cell,TOP1,"Among MICALL1, MRPL23, ARHGEF40, TOP1, and FERD3L, which gene exhibits the highest specificity for Kupffer cells and stands out as the most promising target for Hepatoblastoma therapy?","Among MICALL1, MRPL23, ARHGEF40, TOP1, and FERD3L, which gene exhibits the highest specificity for Kupffer cells and stands out as the most promising target for Hepatoblastoma therapy? Identify the verified therapeutic targets for hepatoblastoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in kupffer cells as identified in PINNACLE. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NEDD1', 'TUBB4B', 'COPZ2', 'TRIM11', 'CD274']",Hepatoblastoma,kupffer cell,TUBB4B,"Among the genes NEDD1, TUBB4B, COPZ2, TRIM11, and CD274, which one exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma?","Among the genes NEDD1, TUBB4B, COPZ2, TRIM11, and CD274, which one exhibits the highest cell-type specificity in Kupffer cells for targeting hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which Kupffer cell–activated genes in PINNACLE overlap with these targets to form a set of hepatoblastoma cell-type–specific candidates. Compute the average embedding for this set and then calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence‐based rationale for its biological relevance."
"['POLA1', 'MAX', 'EIF5B', 'AK9', 'DET1']",Hepatoblastoma,kupffer cell,POLA1,"Which gene among POLA1, MAX, EIF5B, AK9, and DET1 exhibits the highest specificity in Kupffer cells for targeting hepatoblastoma?","Which gene among POLA1, MAX, EIF5B, AK9, and DET1 exhibits the highest specificity in Kupffer cells for targeting hepatoblastoma? Identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the Kupffer cell-activated gene set from PINNACLE, forming the cell-type–specific targets for Hepatoblastoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RRM1', 'PSMB1', 'TBCD', 'PCMT1', 'TCTN2']",Hepatoblastoma,kupffer cell,RRM1,"Which gene among RRM1, PSMB1, TBCD, PCMT1, and TCTN2 exhibits the highest cell-type specificity in Kupffer cells, making it the most promising candidate for targeting hepatoblastoma?","Which gene among RRM1, PSMB1, TBCD, PCMT1, and TCTN2 exhibits the highest cell-type specificity in Kupffer cells, making it the most promising candidate for targeting hepatoblastoma? Identify confirmed therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which Kupffer cell–activated genes in PINNACLE overlap with these targets to define cell-type–specific targets for Hepatoblastoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual target. Finally, if one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['ECPAS', 'RBM27', 'POLA2', 'FOXP2', 'CCL13']",Hepatoblastoma,kupffer cell,POLA2,"Which gene among ECPAS, RBM27, POLA2, FOXP2, and CCL13 exhibits the highest cell-type specificity in Kupffer cells, making it the most promising candidate for targeting hepatoblastoma?","Which gene among ECPAS, RBM27, POLA2, FOXP2, and CCL13 exhibits the highest cell-type specificity in Kupffer cells, making it the most promising candidate for targeting hepatoblastoma? Identify and validate therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Then, cross-reference these targets with Kupffer cell–activated genes in PINNACLE to obtain a subset of cell-type–specific targets for Hepatoblastoma. Calculate the average embedding for this subset and compute the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CABLES2', 'MEP1B', 'TRAF3', 'EXOC4', 'PRIM2']",Hepatoblastoma,hepatic stellate cell,PRIM2,"Which gene among CABLES2, MEP1B, TRAF3, EXOC4, and PRIM2 exhibits the highest cell-type specificity in hepatic stellate cells for targeting hepatoblastoma?","Which gene among CABLES2, MEP1B, TRAF3, EXOC4, and PRIM2 exhibits the highest cell-type specificity in hepatic stellate cells for targeting hepatoblastoma? Determine the validated therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE database. Identify the overlap between these targets and the hepatic stellate cell–activated genes in PINNACLE, treating this intersecting set as the cell-type–specific targets for Hepatoblastoma. Next, compute the average embedding vector for these genes and calculate the cosine similarity between this reference vector and each individual target’s embedding. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GARS1', 'FZD10', 'TOP1', 'SLC6A12', 'PSMG1']",Hepatoblastoma,hepatic stellate cell,TOP1,"Which gene among GARS1, FZD10, TOP1, SLC6A12, and PSMG1 shows the highest specificity for expression in hepatic stellate cells, making it the most promising candidate for targeting hepatoblastoma?","Which gene among GARS1, FZD10, TOP1, SLC6A12, and PSMG1 shows the highest specificity for expression in hepatic stellate cells, making it the most promising candidate for targeting hepatoblastoma? Identify the validated therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with hepatic stellate cell–activated genes in PINNACLE, and calculate the average embedding of this overlapping set as a reference. Then, compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HIF1A', 'PDGFRB', 'LGALS9C', 'RHOBTB1', 'PGLS']",Hepatoblastoma,hepatic stellate cell,PDGFRB,"Which gene among HIF1A, PDGFRB, LGALS9C, RHOBTB1, and PGLS exhibits the highest cell-type specificity in hepatic stellate cells, making it the most suitable candidate for targeting hepatoblastoma?","Which gene among HIF1A, PDGFRB, LGALS9C, RHOBTB1, and PGLS exhibits the highest cell-type specificity in hepatic stellate cells, making it the most suitable candidate for targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma based on PINNACLE cell-type–specific embeddings. Next, determine which of these targets overlap with PINNACLE’s hepatic stellate cell-activated genes to define the cell-type–specific targets for hepatoblastoma. Compute the average embedding of this overlapping set as a reference vector and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TOP2B', 'TRAF3IP3', 'SRM', 'ARHGEF2', 'GTF2A2']",Hepatoblastoma,hepatic stellate cell,TOP2B,"Among the genes TOP2B, TRAF3IP3, SRM, ARHGEF2, and GTF2A2, which one exhibits the highest specificity for hepatic stellate cells in the context of targeting hepatoblastoma?","Among the genes TOP2B, TRAF3IP3, SRM, ARHGEF2, and GTF2A2, which one exhibits the highest specificity for hepatic stellate cells in the context of targeting hepatoblastoma? Identify the verified therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the hepatic stellate cell–activated genes in PINNACLE, and calculate the average embedding of this overlapping set as a reference. For each target, compute the cosine similarity between its embedding and this reference. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['VSIG1', 'TOP2A', 'KDM4C', 'ZRSR2P1', 'LTB4R']",Hepatoblastoma,hepatic stellate cell,TOP2A,"Which gene among VSIG1, TOP2A, KDM4C, ZRSR2P1, and LTB4R exhibits the highest specificity of expression in hepatic stellate cells, making it the most promising target for hepatoblastoma therapy?","Which gene among VSIG1, TOP2A, KDM4C, ZRSR2P1, and LTB4R exhibits the highest specificity of expression in hepatic stellate cells, making it the most promising target for hepatoblastoma therapy? Identify the verified therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which hepatic stellate cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific therapeutic targets. Next, compute the average embedding for this set as a reference, and calculate the cosine similarity between this reference and each individual target. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['TUBB', 'SSX1', 'EMILIN2', 'RABEPK', 'BCLAF1']",Hepatoblastoma,hepatic stellate cell,TUBB,"Among the candidate genes TUBB, SSX1, EMILIN2, RABEPK, and BCLAF1, which one exhibits the highest specificity for hepatic stellate cells in the context of targeting hepatoblastoma?","Among the candidate genes TUBB, SSX1, EMILIN2, RABEPK, and BCLAF1, which one exhibits the highest specificity for hepatic stellate cells in the context of targeting hepatoblastoma? Identify the verified therapeutic targets for Hepatoblastoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the hepatic stellate cell-activated genes annotated in PINNACLE to define the cell-type–specific targets for Hepatoblastoma. Calculate the average embedding of this overlapping set, and then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a brief, evidence-based explanation of its biological relevance."
"['TYMS', 'C11orf45', 'PRDM10', 'HIGD1B', 'PRPF38A']",Hepatoblastoma,hepatic stellate cell,TYMS,"Of the genes TYMS, C11orf45, PRDM10, HIGD1B, and PRPF38A, which one exhibits the highest cell-type-specific expression in hepatic stellate cells, making it the most promising candidate for targeted hepatoblastoma therapy?","Of the genes TYMS, C11orf45, PRDM10, HIGD1B, and PRPF38A, which one exhibits the highest cell-type-specific expression in hepatic stellate cells, making it the most promising candidate for targeted hepatoblastoma therapy? Identify the verified therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in hepatic stellate cells in the PINNACLE dataset. Compute the average embedding for this overlapping set as a reference and calculate the cosine similarity between this reference and each individual target embedding. If a single gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PLXNA4', 'FLT1', 'PARS2', 'IPO5', 'ESPL1']",Hepatoblastoma,hepatic stellate cell,FLT1,"Among PLXNA4, FLT1, PARS2, IPO5, and ESPL1, which gene exhibits the greatest cell-type specificity in hepatic stellate cells and thus represents the most promising target for hepatoblastoma?","Among PLXNA4, FLT1, PARS2, IPO5, and ESPL1, which gene exhibits the greatest cell-type specificity in hepatic stellate cells and thus represents the most promising target for hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and retrieve their cell type–specific embeddings from PINNACLE. Next, determine which hepatic stellate cell–activated genes in PINNACLE overlap with these targets, defining this overlapping set as the cell type–specific targets for hepatoblastoma. Compute the average embedding of this set, then calculate the cosine similarity between this average embedding and the individual target embeddings. If one gene shows a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRIM2', 'MARCHF6', 'PYCR1', 'RIPOR2', 'SLC14A1']",Hepatoblastoma,hepatic stellate cell,PRIM2,"Which gene among PRIM2, MARCHF6, PYCR1, RIPOR2, and SLC14A1 demonstrates the highest cell-type specificity in hepatic stellate cells, making it the most promising target for hepatoblastoma therapy?","Which gene among PRIM2, MARCHF6, PYCR1, RIPOR2, and SLC14A1 demonstrates the highest cell-type specificity in hepatic stellate cells, making it the most promising target for hepatoblastoma therapy? Identify the verified therapeutic targets for Hepatoblastoma and retrieve their corresponding cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with hepatic stellate cell-activated genes in PINNACLE, and compute the average embedding of the overlapping set. Then, calculate the cosine similarity between this averaged embedding and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ACTR10', 'FAM71F2', 'MOSPD3', 'PDGFRB', 'PCBP3']",Hepatoblastoma,hepatic stellate cell,PDGFRB,"Which gene—ACTR10, FAM71F2, MOSPD3, PDGFRB, or PCBP3—exhibits the highest cell-type specificity in hepatic stellate cells relevant to hepatoblastoma targeting?","Which gene—ACTR10, FAM71F2, MOSPD3, PDGFRB, or PCBP3—exhibits the highest cell-type specificity in hepatic stellate cells relevant to hepatoblastoma targeting? Using the PINNACLE dataset, identify the validated therapeutic targets for Hepatoblastoma and extract their cell-type–specific embeddings. Next, determine which hepatic stellate cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific Hepatoblastoma targets. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this average and each individual target’s embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['FLT1', 'CCK', 'ZNF512', 'BHLHB9', 'POU3F3']",Hepatoblastoma,hepatic stellate cell,FLT1,"Which gene among FLT1, CCK, ZNF512, BHLHB9, and POU3F3 demonstrates the highest specificity for hepatic stellate cells, thereby representing the best candidate for hepatoblastoma targeting?","Which gene among FLT1, CCK, ZNF512, BHLHB9, and POU3F3 demonstrates the highest specificity for hepatic stellate cells, thereby representing the best candidate for hepatoblastoma targeting? Identify the verified therapeutic targets for Hepatoblastoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which genes activated in hepatic stellate cells overlap with these targets, as these represent the cell-type-specific targets. For this overlapping set, compute the average embedding and then calculate the cosine similarity between this average reference and each target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DENND1B', 'TOP2A', 'CISH', 'ASCC2', 'TEX13A']",Hepatoblastoma,hepatic stellate cell,TOP2A,"Among DENND1B, TOP2A, CISH, ASCC2, and TEX13A, which gene exhibits the highest specificity for hepatic stellate cells and is therefore the most promising target for hepatoblastoma therapy?","Among DENND1B, TOP2A, CISH, ASCC2, and TEX13A, which gene exhibits the highest specificity for hepatic stellate cells and is therefore the most promising target for hepatoblastoma therapy? Identify the validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the hepatic stellate cell-activated genes in PINNACLE. Calculate the average embedding for these overlapping genes to use as a reference, and then compute the cosine similarity between this reference and the embedding of each target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['EP400P1', 'RND1', 'TOP2B', 'SIGLEC7', 'ZBTB20']",Hepatoblastoma,hepatic stellate cell,TOP2B,"Among EP400P1, RND1, TOP2B, SIGLEC7, and ZBTB20, which gene exhibits the most specific expression in hepatic stellate cells and thus represents the best candidate for targeted hepatoblastoma therapy?","Among EP400P1, RND1, TOP2B, SIGLEC7, and ZBTB20, which gene exhibits the most specific expression in hepatic stellate cells and thus represents the best candidate for targeted hepatoblastoma therapy? Identify and validate therapeutic targets for Hepatoblastoma, then extract their cell-type–specific embeddings from PINNACLE. Next, determine which hepatic stellate cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for Hepatoblastoma. Compute the average embedding of these genes to serve as a reference profile, and calculate the cosine similarity between this profile and each individual target's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MUL1', 'CKAP4', 'ATP5MK', 'CREBBP', 'TUBB']",Hepatoblastoma,hepatic stellate cell,TUBB,"Which gene among MUL1, CKAP4, ATP5MK, CREBBP, and TUBB exhibits the highest specificity for hepatic stellate cells, thereby representing the optimal candidate for targeted Hepatoblastoma therapy?","Which gene among MUL1, CKAP4, ATP5MK, CREBBP, and TUBB exhibits the highest specificity for hepatic stellate cells, thereby representing the optimal candidate for targeted Hepatoblastoma therapy? Using the validated therapeutic targets for Hepatoblastoma, retrieve their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and hepatic stellate cell-activated genes in PINNACLE to define a set of cell-type–specific targets for Hepatoblastoma. Calculate the average embedding of this gene set to serve as a reference and compute the cosine similarity between this reference and the individual target embeddings. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['CILK1', 'SLC30A8', 'CACUL1', 'SRM', 'TYMS']",Hepatoblastoma,hepatic stellate cell,TYMS,"Among CILK1, SLC30A8, CACUL1, SRM, and TYMS, which gene shows the greatest specificity for hepatic stellate cells and is therefore the best candidate for targeted intervention in Hepatoblastoma?","Among CILK1, SLC30A8, CACUL1, SRM, and TYMS, which gene shows the greatest specificity for hepatic stellate cells and is therefore the best candidate for targeted intervention in Hepatoblastoma? Identify validated therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with hepatic stellate cell-activated genes in the dataset. Using the overlapping set as hepatoblastoma cell-type–specific targets, compute their average embedding to serve as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYSM1', 'SLIRP', 'NIPAL4', 'TOP1', 'IRF7']",Hepatoblastoma,hepatic stellate cell,TOP1,"Which gene among MYSM1, SLIRP, NIPAL4, TOP1, and IRF7 exhibits the highest specificity in hepatic stellate cells for potential hepatoblastoma targeting?","Which gene among MYSM1, SLIRP, NIPAL4, TOP1, and IRF7 exhibits the highest specificity in hepatic stellate cells for potential hepatoblastoma targeting? Identify validated therapeutic targets for hepatoblastoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, identify which hepatic stellate cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding for this overlap set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['CLNS1A', 'GPRC5A', 'TOP1', 'SKAP2', 'ULBP3']",Hepatoblastoma,hepatic stellate cell,TOP1,"Which gene among CLNS1A, GPRC5A, TOP1, SKAP2, and ULBP3 exhibits the highest specificity for hepatic stellate cells in the context of targeting hepatoblastoma?","Which gene among CLNS1A, GPRC5A, TOP1, SKAP2, and ULBP3 exhibits the highest specificity for hepatic stellate cells in the context of targeting hepatoblastoma? Identify validated therapeutic targets for Hepatoblastoma and extract their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlapping genes between these targets and the hepatic stellate cell–activated genes within PINNACLE, forming the cell-type–specific target set for Hepatoblastoma. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based justification for its biological relevance."
"['D2HGDH', 'CCDC40', 'FLT1', 'NBEA', 'CDX1']",Hepatoblastoma,hepatic stellate cell,FLT1,"Among the genes D2HGDH, CCDC40, FLT1, NBEA, and CDX1, which one exhibits the highest specificity for hepatic stellate cells in the context of targeting hepatoblastoma?","Among the genes D2HGDH, CCDC40, FLT1, NBEA, and CDX1, which one exhibits the highest specificity for hepatic stellate cells in the context of targeting hepatoblastoma? Identify the validated therapeutic targets for hepatoblastoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which genes, known to be activated in hepatic stellate cells, overlap with these targets. Calculate the average embedding of this overlapping gene set as a reference, and compute the cosine similarity between this reference and the embedding of each target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PDGFRB', 'MPIG6B', 'KLRB1', 'TRAPPC6A', 'HEMK1']",Hepatoblastoma,hepatic stellate cell,PDGFRB,"Among the genes PDGFRB, MPIG6B, KLRB1, TRAPPC6A, and HEMK1, which one shows the highest cell-type specific expression in hepatic stellate cells, making it the most promising candidate for targeted therapy in hepatoblastoma?","Among the genes PDGFRB, MPIG6B, KLRB1, TRAPPC6A, and HEMK1, which one shows the highest cell-type specific expression in hepatic stellate cells, making it the most promising candidate for targeted therapy in hepatoblastoma? Identify the verified therapeutic targets for Hepatoblastoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with hepatic stellate cell-activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of this subset as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRKN', 'TUBB', 'HYPK', 'FCRL3', 'CAPRIN2']",Hepatoblastoma,hepatic stellate cell,TUBB,"Which gene among PRKN, TUBB, HYPK, FCRL3, and CAPRIN2 exhibits the most specific expression in hepatic stellate cells, thereby representing the most promising target for Hepatoblastoma therapy?","Which gene among PRKN, TUBB, HYPK, FCRL3, and CAPRIN2 exhibits the most specific expression in hepatic stellate cells, thereby representing the most promising target for Hepatoblastoma therapy? Identify the validated therapeutic targets for hepatoblastoma and obtain their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with hepatic stellate cell-activated genes in PINNACLE to define the cell-type-specific target set. Compute the average embedding of this overlapping set to serve as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If a single gene shows significantly higher similarity than the others, select it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
